Effects of over-expression of LOC92912 gene on cell cycle progression

Iranian Journal of Medical Sciences

Volumn 34, Issue 4, 2009, Pages 277-284

  Seghatoleslam, Atefeh ^a   Zambrano, Alberto ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Cell cycle; Clonogenicity; LOC92912; Transfection

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL SHAPE; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; LOC92912 GENE;

EID: 73349122317     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Seyedmajidi M, Faizabadi M. Squamous cell carcinoma of the tongue in a 13-year-old boy. Arch Iran Med 2008; 11: 341-3.
2. Papadimitrakopoulou VA. Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal. Curr Opin Oncol 2000; 12: 240-5.
3. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003; 260: 502-8.
4. Shibuya K., Mathers CD, Boschi-Pinto C, et al. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002; 2: 37.
5. Lissowska J, Zatonski W. [Tumors of the larynx in Poland compared to other European countries. Etiologic hypothesis]. Otolaryngol Pol 1992; 46: 211-6.
6. Parker SL., Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5-27.
7. Nagai MA. Genetic alterations in head and neck squamous cell carcinomas. Braz J Med Biol Res 1999; 32: 897-904.
8. Brennan JA., Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-7.
9. Wynder EL, Stellman SD. Impact of long-term filter cigarette usage on lung and larynx cancer risk: a case-control study. J Natl Cancer Inst 1979; 62: 471-7.
10. Spitz MR. Epidemiology and risk factors for head and neck cancer. Semin Oncol 1994; 21: 281-8.
11. Jovanovic A., Schulten EA., Kostense PJ. et al. Tobacco and alcohol related to the anatomical site of oral squamous cell carcinoma. J Oral Pathol Med 1993; 22: 459-62.
12. Gissmann L, Wolnik L, Ikenberg H, et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers.. Proc Natl Acad Sci U S A 1983; 80: 560-3.
13. Mineta H, Ogino T, Amano HM, et al. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res 1998; 18: 4765-8.
14. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-31.
15. Fahraeus R, Fu HL, Ernberg I, et al. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988; 42: 329-38.
16. Ankathil R, Mathew A, Joseph F, Nair MK. Is oral cancer susceptibility inherited? Report of five oral cancer families. Eur J Cancer B Oral Oncol 1996; 32B: 63-7.
17. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-92.
18. Lemaire F, Millon R, Young J, et al. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 2003; 89: 1940-9.
19. Cromer A, Carles A, Millon R, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 2004; 23: 2484-98.
20. Lemaire F, Millon R, Muller D, et al. Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma. Br J Cancer 2004; 91: 258-61.
21. Carles A, Millon R, Cromer A, et al. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene 2006; 25: 1821-31.
22. Seghatoleslam A., Zambrano A, Millon R, et al. Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours. Biochem Biophys Res Commun 2006; 339: 422-9.
23. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-52.
24. Oehrl W, Panayotou G. Modulation of growth factor action by the extracellular matrix. Connect Tissue Res 2008; 49: 145-8.
25. Goranov AI, Cook M, Ricicova M, et al. The rate of cell growth is governed by cell cycle stage. Genes Dev 2009; 23: 1408-22.
26. Boonstra J, Moes MJ. Signal transduction and actin in the regulation of G1-phase progression. Crit Rev Eukaryot Gene Expr 2005; 15: 255-76.
27. Chun JT, Santella L. The actin cytoskeleton in meiotic maturation and fertilization of starfish eggs. Biochem Biophys Res Commun 2009; 384: 141-3.
28. Kunda P, Baum B. The actin cytoskeleton in spindle assembly and positioning. Trends Cell Biol 2009; 19: 174-9.
29. Gieni RS, Hendzel MJ. Actin dynamics and functions in the interphase nucleus: moving toward an understanding of nuclear polymeric actin. Biochem Cell Biol 2009; 87: 283-306.
30. Bonner MK, Skop AR. Cell division screens and dynamin. Biochem Soc Trans 2008; 36: 431-5.
31. Ikeda K, Shirao T, Toda M, et al. Effect of a neuron-specific actin-binding protein, drebrin A, on cell-substratum adhesion. Neurosci Lett 1995; 194: 197-200.
32. Adachi M, Taki T, Higashiyama M, et al. Significance of integrin alpha5 gene expression as a prognostic factor in nodenegative non-small cell lung cancer. Clin Cancer Res 2000; 6: 96-101.